Option Care Health (OPCH)
(Real Time Quote from BATS)
$27.24 USD
+0.26 (0.96%)
Updated Jul 10, 2024 01:36 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Option Care (OPCH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.57 | $43.00 | $36.00 | 46.66% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Option Care comes to $39.57. The forecasts range from a low of $36.00 to a high of $43.00. The average price target represents an increase of 46.66% from the last closing price of $26.98.
Analyst Price Targets (7 )
Broker Rating
Option Care currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, eight are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/24/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
4/24/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
3/31/2024 | Goldman Sachs | Jamie Perse | Strong Buy | Strong Buy |
3/4/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
2/29/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 8 |
Average Target Price | $39.57 |
LT Growth Rate | 17.30% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 54 of 252 |
Current Quarter EPS Est: | 0.28 |